register

News & Trends - Pharmaceuticals

BMS and Roche welcome Australia’s first industry-led Genomics Alliance in precision medicine

Health Industry Hub | November 11, 2020 |

Pharma News: The first Industry Genomics Network Alliance (InGeNA) has been established by Australasian Institute of Digital Health (AIDH) with $300,000 in funding from MTPConnect’s Industry Growth Centre Project Fund.

The new Alliance includes 13 founding member companies, including Roche and Bristol Myers Squibb (BMS), and aims to unlock the potential of Australia’s precision medicine sector to improve health outcomes for all Australians and to build a stronger and more diverse industry that can contribute internationally to the global genomics market estimated to reach USD 41.2 billion by 2025.

MTPConnect Managing Director and CEO, Dr Dan Grant, said “This new MTPConnect-supported Alliance is a potential game-changer which will help to integrate genomics and precision medicine further into the Australian healthcare system. There are many opportunities for this new health technology ranging from improving diagnoses and providing more tailored treatments to screening programs, clinical trial recruitment and general healthcare improvement.”

Mr Neil MacGregor, Managing Director of Bristol Myers Squibb Australia, said “We welcome the formation of InGeNA and the development of programs to embed genomics across Australian Healthcare sector so that patients may benefit from precision healthcare.”

Richard Woodfield, Roche Australia Medical Director, said “InGeNA represents an important step in fostering and facilitating the collaboration required to integrate genomics into healthcare in Australia. Genomics is one of the key technologies that will drive the evolution of healthcare by enabling a more personalised approach to treatment. We look forward to participating in the work of the Alliance to accelerate the benefits of personalised healthcare and help ensure that every patient receives the right care, at the right time.”

InGeNA appointed AIDH Fellow and digital health leader David Bunker as the inaugural Chair. David established Queensland Genomics and is currently Executive Director of Brisbane Diamantina Health Partners (BDHP).

“Globally, genomics is expanding at an exponential rate and it is estimated between 100 million and as many as 2 billion – human genomes could be sequenced by 2025,” David Bunker said. “We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”

AIDH CEO Dr Louise Schaper said “MTPConnect’s support through the Growth Centre Project Fund has been critical to the establishment of the new Alliance.”

With the Australasian Institute of Digital Health (AIDH) as consortium lead, the 13 founding member companies bring matched funds and represent key contributors of the genomics and precision medicine industry:

  • 23 Strands
  • AbbVie
  • Amgen
  • Amicus
  • Applied Precision Medicine
  • Bristol Myers Squibb
  • Illumina
  • Janssen
  • Qiagen
  • Roche
  • Sanofi
  • Thermo Fisher
  • TrakGene

News & Trends - Pharmaceuticals

Sanofi's departing Country Lead leaves three-decade legacy of strategic, compassionate leadership

Sanofi’s departing Country Lead leaves three-decade legacy of strategic, compassionate leadership

Health Industry Hub | April 17, 2024 |

Pharma News: In a significant development for Sanofi’s local operations, Karen Hood, a seasoned leader with 28 years of invaluable […]

More


Human Resources

AbbVie appoints new HR Director with diverse expertise across healthcare

AbbVie appoints new HR Director with diverse expertise across healthcare

Health Industry Hub | April 17, 2024 |

AbbVie has appointed a new Human Resources Director for Australia and New Zealand. Ally Jonas assumed the role earlier this […]

More


Digital & Innovation

Department of Health hits milestone in digital transformation

Department of Health hits milestone in digital transformation

Health Industry Hub | April 17, 2024 |

Digital & Innovation: The Department of Health and Aged Care has reached the midpoint of its digital transformation journey. While […]

More


News & Trends - Pharmaceuticals

Paradigm-changing outcomes for patients with acute myeloid leukaemia

Paradigm-changing outcomes for patients with acute myeloid leukaemia

Health Industry Hub | April 17, 2024 |

Pharma News: Australian researchers have found a new combination treatment to treat a form of leukaemia that prolongs remission. A […]

More


This content is copyright protected. Please subscribe to gain access.